Imaging brain neuronal activity using functionalized magnetonanoparticles and MRI

Brain Topography

Volumn 25, Issue 4, 2012, Pages 374-388

  Akhtari, Massoud ^a   Bragin, Anatol ^b   Moats, Rex ^c   Frew, Andrew ^b   Mandelkern, Mark ^d  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

2 deoxy glucose; Brain; Contrast; Function; Magnetonanoparticles; MRI; Targeted

Indexed keywords

2 DEOXY GLUCOSE; CARBON 14; DEXTRAN; GLUCOSE DERIVATIVE; IRON OXIDE; MAGNETITE NANOPARTICLE; UNCLASSIFIED DRUG;

ACUTE DISEASE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; AUTORADIOGRAPHY; BLOOD BRAIN BARRIER; BRAIN FUNCTION; BRAIN NERVE CELL; CHRONIC DISEASE; CONTRAST ENHANCEMENT; ELECTROENCEPHALOGRAM; FUNCTIONAL MAGNETIC RESONANCE IMAGING; HISTOPATHOLOGY; NEGATIVE CONTRAST ENHANCEMENT; NONHUMAN; PRIORITY JOURNAL; RAT; SEIZURE;

AFFERENT PATHWAYS; ANIMALS; BRAIN; BRAIN MAPPING; CONVULSANTS; DEXTRANS; DISEASE MODELS, ANIMAL; ELECTRIC STIMULATION; ELECTROENCEPHALOGRAPHY; FERRIC COMPOUNDS; INOSITOL; MAGNETIC RESONANCE IMAGING; MICE; NEURONS; PENTYLENETETRAZOLE; PILOCARPINE; RATS; RATS, SPRAGUE-DAWLEY; REST; SEIZURES; VIBRISSAE;

EID: 84866914036     PISSN: 08960267     EISSN: 15736792     Source Type: Journal    
DOI: 10.1007/s10548-012-0231-4     Document Type: Article

References (36)

1. Akhtari M, Bragin A, Cohen M, Moats R, Brenker F, Lynch MD, Harry Vinters HH, Engel J (2008) Targeted magnetonanoparticles in the diagnosis, localization, and enhanced therapy of epilepsy. Epilepsia 49(8):1419-14130 [Epub 2008 May 8]
2. Akhtari M et al (2009) Patent # WO 2009/123734 A1
3. Anzai Y, Piccoli CW, Outwater EK, Stanford W, Bluemke DA, Nurenberg P, Saini S, Maravilla KR, Feldman DE, Schmiedl UP, Brunberg JA, Francis IR, Harms SE, Som PM, Tempany CM (2003). Evaluation of neck and body metastases to nodes with ferumoxtran 10-enhanced MR imaging: phase III safety and efficacy study. Radiology 228(3):777-788
4. Aydogan B, Li J, Rajh T, Chaudhary A, Chmura SJ (2010) AuNPDG: eoxyglucose-labeled gold nanoparticles as x-ray computed tomography contrast agents for cancer imaging. Mol Imaging Biol 12:463-467
5. Beers Y (1953) Introduction to the theory of error. Addison-Wesley, Cambridge
6. Bragin A, Wilson CL, Almajano J, Mody I, Engel J Jr (2004) High frequency oscillations after status epilepticus: epileptogenesis and seizure genesis. Epilepsia 45:1017-1023
7. Cornford EM, Hyman S (2005) Localization of brain endothelial luminal and abluminal transporters with immunogold electron microscopy. NeuroRx 2:27-43
8. Corot C, Robert P, Idée JM, Port M (2006) Recent advances in iron oxide nanocrystal technology for medical imaging. Adv Drug Deliv Rev 58(14):1471-504 [Epub 2006 Sep 30]
9. de Jong BM, van de Hoeven JH, Pruim J, Meertens JH, van der Naalt J (2008) Cortico-thalamic activation in generalized status epilepticus, a PET study. Clin Neurol Neurosurg 110:182-185
10. Dietrich WD, Ginsberg MD, Busto R, Smith DW (1985) Metabolic alterations in rat somatosensory cortex following unilateral vibrissal removal. J Neurosci 5(4):874-880
11. Doherty GJ, McMahon HT (2009) Mechanisms of endocytosis. Annu Rev Biochem 78:857-902
12. Guo Y, Gao F, Wang S, Ding Y, Zhang H, Wang J, Ding MP (2009). In vivo mapping of temporospatial changes in glucose utilization in rat brain during epileptogenesis: an 18F-fluorodeoxyglucosesmall animal positron emission tomography study. Neuroscience 162(4):972-979. [Epub 2009 May 27]
13. Handforth A, Treiman DM (1995a) Functional mapping of the early stages of status epilepticus: a 14C-2-deoxyglucose study in the lithium-pilocarpine model in rat. Neuroscience 64(4):1057-1073
14. Handforth A, Treiman DM (1995b) Functional mapping of the late stages of status epilepticus: a 14C-2-deoxyglucose study in the lithium-pilocarpine model in rat. Neuroscience 64(4):1075-1089
15. Hosokawa C, Ochi H, Yamagami S, Yamada R (1997) Regional cerebral blood flow and glucose utilization in spontaneously epileptic EL mice. J Nucl Med 38(4)613-616
16. Hyder F, Behar KL, Martin MA, Blamire AM, Shulman RG. (1994) Dynamic magnetic resonance imaging of the rat brain during forepaw stimulation. J Cereb Blood Flow Metab 14(4):649-655
17. Islam T, Harisinghani MG (2009) Overview of nanoparticle use in cancer imaging. Cancer Biomark 5(2):61-67
18. Islam T, Wolf G (2009) The pharmacokinetics of the lymphotropic nanoparticle MRI contrast agent ferumoxtran-10. Cancer Biomark 5(2):69-73
19. Ivanov AI (2008) Pharmacological inhibition of endocytic pathways: is it specific enough to be useful? Methods Mol Biol 2008(440):15-33
20. Jackson GD, Connelly A, Cross JH, Gordon I, Gadian DG (1994) Functional magnetic resonance imaging of focal seizures. Neurology 44(5):850-856
21. Kety SS, Schmidt CF (1945) The determination of cerebral blood flow in man by the use of nitrous oxide in low concentrations. Am J Physiol 143:53-66
22. Kornblum HI, Araujo DM, Annala AJ, Tatsukawa KJ, Phelps ME, Cherry SR (2000) In vivo imaging of neuronal activation and plasticity in the rat brain by high resolution positron emission tomography (microPET). Nat Biotechnol 18(6):655-660
23. la Fougère C, Rominger A, Förster S, Geisler J, Bartenstein P (2009) PET and SPECT in epilepsy: A critical review. Epilepsy Behav 15:50-55
24. London ED, Connolly RJ, Szikszay M, Wamsley JK, Dam M (1988) Effects of nicotine on local cerebral glucose utilization in the rat. J Neurosci 8(10):3920-3928
25. Lutz AM, Weishaupt D, Persohn E, Goepfert K, Froehlich J, Sasse B, Gottschalk J, Marincek B, Kaim AH (2005) Imaging of macrophages in soft-tissue infection in rats: relationship between ultrasmall superparamagnetic iron oxide dose and MR signal characteristics. Radiology 234(3):765-775 [Epub 2005 Jan 21]
26. Molday HS (1984) US Pat 2(452):773
27. Muldoon LL, Sandor M, Pinkston, Neuwlet EA (2005) Imaging, distribution, and toxicity of superparamagnetic iron oxide magnetic resonance nanoparticles in the rat brain and intracerebral tumor. Neurosurgery 57(4):785-796; discussion 785-796
28. Pain F, Besret L, Vaufrey F, Grégoire MC, Pinot L, Gervais P, Ploux L, Bloch G, Mastrippolito R, Lanièce P, Hantraye P (2002) In vivo quantification of localized neuronal activation and inhibition in the rat brain using a dedicated high temporalresolution beta ?-sensitive microprobe. Proc Natl Acad Sci USA 99(16):10807-10812 [Epub 2002 Jul 22]
29. Paxinos G, Watson C (1997) The rat brain in stereotaxic coordinates. Academic Press, San Diego
30. Racine RJ (1972) Modification of seizure activity by electrical stimulation. II. Motor seizure. Electroencephalogr Clin Neurophysiol 32:281-294
31. Ravasi L, Shimoji K, Soto-Montenegro ML, Esaki T, Seidel J, Sokoloff L, Schmidt K (2011) Use of [18F]fluorodeoxyglucose and the ATLAS small animal PET scanner to examine cerebral functional activation by whisker stimulation in unanesthetized rats. Nucl Med Commun 32(5):336-342
32. Reivich M, Kuhl D, Wolf A, Greenberg J, Phelps M, Ido T, Casella V, Fowler J, Hoffman E, Alavi A, Son P, Sokoloff L (1979) The [18F] fluorodeoxyglucose method for the measurement of local cerebral glucose utilization in man. Circ Res 44:127-137
33. Scorza FA, Sanabria ERG, Calderazzo L, Cavalheiro EA (1998) Glucose utilization during interictal intervals in an epilepsy model induced by pilocarpine: a qualitative study. Epilepsia 39(10):1041-1045
34. Shahar E, Goldsher D, Genizi J, Ravid S, Keidar Z (2008) Intractable gelastic seizures during infancy: ictal positron emission tomography (PET) Demonstrating epileptiform activity within the hypothalamic hamartoma. J Child Neurol 23:235-239. Originally published online Dec 26, 2007
35. Veiseh O, Sun C, Fang C, Bhattarai N, Gunn J, Kievit F, Du K, Pullar B, Lee D, Ellenbogen RG, Olson J, Zhang M (2009) Specific targeting of brain tumors with an optical/magnetic resonance imaging nanoprobe across the blood-brain barrier. Cancer Res 69(15):6200-62007 [Epub 2009 Jul 28]
36. Yan H, Wang J, Yi P, Lei H, Zhan C, Xie C, Feng L, Qian J, Zhu J, Lu W, Li C (2011) Imaging brain tumor by dendrimer-based optical/paramagnetic nanoprobe across the blood-brain barrier. Chem Commun 47:8130-8132